Why SH-SY5Y cells should be differentiated

NeuroToxicology

Volumn 31, Issue 1, 2010, Pages 164-165

  Luchtman, Dirk W ^a,b   Song, Cai ^a,b  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Differentiation; Dopaminergic neuron; Retinoic acid; SH SY5Y

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DOPAMINE TRANSPORTER; OXIDOPAMINE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; TYROSINE 3 MONOOXYGENASE;

CELL PROLIFERATION; CELL VIABILITY; DOPAMINERGIC NERVE CELL; HUMAN; LETTER; MITOSIS; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; NEUROBLASTOMA; NEURONS;

EID: 74249088302     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.10.015     Document Type: Letter

References (9)

1. Cheung Y., Lau W.L., Yu M., Lai C.S., Yeung S., So K., et al. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 30 (2009) 127-135
2. Constantinescu R., Constantinescu A.T., Reichmann H., and Janetzky B. Neuronal differentiation and long-term culture of the human neuroblastoma line SH SY5Y. J Neural Trans, Suppl 72 (2007) 17-28
3. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
4. Liberto C.M., Albrecht P.J., Herx L.M., Yong V.W., and Levison S.W. Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 89 (2004) 1092-1100
5. Påhlman S., Hoehner J.C., Nånberg E., Hedborg F., Fagerström S., Gestblom C., et al. Differentiation and survival influences of growth factors in human neuroblastoma. Eur J Cancer 31 (1995) 453-458
6. Presgraves S.P., Ahmed T., Borwege S., and Joyce J.N. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 5 (2004) 579-598
7. Schwartz J.P., Sheng J.G., Mitsuo K., Shirabe S., and Nishiyama N. Trophic factor production by reactive astrocytes in injured brain. Ann N Y Acad Sci 679 (1993) 226-234
8. Skaper S.D. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol Disord Drug Targets 7 (2008) 46-62
9. Soldner F., Weller M., Haid S., Beinroth S., Miller S.W., Wüllner U., et al. MPP+ inhibits proliferation of PC12 cells by a p21(WAF1/Cip1)-dependent pathway and induces cell death in cells lacking p21(WAF1/Cip1). Exp Cell Res 250 (1999) 75-85